The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review

被引:23
|
作者
Anonychuk, Andrea [1 ,2 ,3 ]
Woo, Gloria [4 ]
Vyse, Andrew [1 ]
Demarteau, Nadia [1 ]
Tricco, Andrea C. [5 ]
机构
[1] GlaxoSmithKline Vaccines, Wavre, Belgium
[2] Abbott Labs, Div Diagnost, Abbott Pk, IL 60064 USA
[3] Abbott Labs, Div Diagnost, Mississauga, ON L5N 3R3, Canada
[4] Univ Toronto, Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
关键词
NEISSERIA-MENINGITIDIS; CONJUGATE VACCINE; UNITED-STATES; SEROGROUP; IMMUNOGENICITY; POLYSACCHARIDE; SAFETY; W-135; INFECTION; ENGLAND;
D O I
10.1007/s40273-013-0057-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. Numerous reports in the literature conclude that IMD outbreaks are associated with substantial costs to society and significant burden on communities due to the cost associated with the prevention of secondary cases. Objective To systematically review the literature on the costs and public health burden associated with IMD outbreaks. Methods Studies were primarily identified through searching MEDLINE and EMBASE. Reports were included if they provided cost data related to the containment of an IMD outbreak after 1990 and were written in English, French, or Spanish. Costs were converted to 2010 United States dollars. Outbreaks were categorized by low-income countries (LIC) and high-income countries (HIC) based on gross domestic product per capita. Outbreak containment strategies were classified as small (e.g., targeting members of the school/institution where the outbreak occurred) or large (e.g., targeting everyone in the community). Results Sixteen articles reporting data on 93 IMD outbreaks fulfilled the eligibility criteria and were included. The majority of outbreaks occurred in HIC. Five studies reported the use of small containment strategies including targeted vaccination and chemoprophylaxis, all occurring in HIC. The average cost per small containment strategy was $299,641 and the average cost per IMD case was $41,857. Eight studies reported large containment strategies involving widespread vaccination targeting a specific age group or community. For HIC, the average cost per large containment strategy was $579,851 and the average cost per IMD case was $55,755. In LIC, the average cost per large containment strategy was $3,407,590 and the average cost per IMD case was $2,222. Conclusion IMD outbreaks were associated with substantial costs. We found that although there were numerous reports on IMD outbreaks, data on containment costs were very limited. More research in this area is warranted.
引用
收藏
页码:563 / 576
页数:14
相关论文
共 50 条
  • [1] The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review
    Andrea Anonychuk
    Gloria Woo
    Andrew Vyse
    Nadia Demarteau
    Andrea C. Tricco
    PharmacoEconomics, 2013, 31 : 563 - 576
  • [2] The Health Burden of Invasive Meningococcal Disease: A Systematic Review
    Strifler, Lisa
    Morris, Shaun K.
    Dang, Vica
    Tu, Hong Anh T.
    Minhas, Ripudaman S.
    Jamieson, Frances B.
    Deeks, Shelley L.
    Crowcroft, Natasha S.
    Sander, Beate
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2016, 5 (04) : 417 - 430
  • [3] Public health management of invasive meningococcal disease outbreaks: worldwide 1973-2018, a systematic review
    Morello, Brianna R.
    Milazzo, Adriana
    Marshall, Helen Siobhan
    Giles, Lynne C.
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [4] Public health management of invasive meningococcal disease
    Pfaff, G
    Walter, K
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2002, 12 (04): : 22 - 22
  • [5] Health economic burden of invasive meningococcal disease in the US
    Möller, J
    Getsios, D
    Caro, J
    El-Hadi, W
    O'Brien, JA
    Chevat, C
    Coudeville, L
    Nguyen, VH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : S99 - S99
  • [6] PUBLIC HEALTH COSTS ASSOCIATED WITH OUTBREAKS OF MENINGOCCOCAL DISEASE: A SYSTEMATIC REVIEW
    Anonychuk, A.
    Vyse, A.
    Woo, G.
    Tricco, A. C.
    VALUE IN HEALTH, 2011, 14 (07) : A401 - A401
  • [7] Costs of Invasive Meningococcal Disease: A Global Systematic Review
    Bing Wang
    Renee Santoreneos
    Hossein Afzali
    Lynne Giles
    Helen Marshall
    PharmacoEconomics, 2018, 36 : 1201 - 1222
  • [8] Costs of Invasive Meningococcal Disease: A Global Systematic Review
    Wang, Bing
    Santoreneos, Renee
    Afzali, Hossein
    Giles, Lynne
    Marshall, Helen
    PHARMACOECONOMICS, 2018, 36 (10) : 1201 - 1222
  • [9] Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review
    Jing Shen
    Najida Begum
    Yara Ruiz-Garcia
    Federico Martinon-Torres
    Rafik Bekkat-Berkani
    Kinga Meszaros
    BMC Public Health, 22
  • [10] Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review
    Shen, Jing
    Begum, Najida
    Ruiz-Garcia, Yara
    Martinon-Torres, Federico
    Bekkat-Berkani, Rafik
    Meszaros, Kinga
    BMC PUBLIC HEALTH, 2022, 22 (01)